HomePTPI • NASDAQ
add
Petros Pharmaceuticals Inc
Previous close
$0.32
Day range
$0.31 - $0.34
Year range
$0.28 - $2.27
Market cap
3.07M USD
Avg Volume
111.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.42M | -28.71% |
Operating expense | 3.37M | -14.45% |
Net income | -662.03K | 74.00% |
Net profit margin | -46.57 | 63.54% |
Earnings per share | -0.37 | — |
EBITDA | -1.56M | 4.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.46M | 1.02% |
Total assets | 25.17M | -12.38% |
Total liabilities | 15.98M | 1.27% |
Total equity | 9.19M | — |
Shares outstanding | 9.61M | — |
Price to book | 0.37 | — |
Return on assets | -20.56% | — |
Return on capital | -31.89% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -662.03K | 74.00% |
Cash from operations | -1.66M | -190.59% |
Cash from investing | — | — |
Cash from financing | -1.96M | -439.19% |
Net change in cash | -3.62M | -287.13% |
Free cash flow | -2.05M | -1,436.14% |
About
Founded
2020
Website
Employees
21